Yong Jiang

Yong Jiang

Auto-generated profile, based on publicly available information

Yong Jiang

Chengdu University of Traditional Chinese Medicine, School of Basic Medical Sciences

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Technology and Health Care
Verified
Journal Article
Open access
PDF file
MLMi Li
Mi Li
KLKai Li
Kai Li
HZHong Zhang
Hong Zhang
YJYong Jiang
Yong Jiang
BACKGROUND AND OBJECTIVE: Post-traumatic stress disorder (PTSD) is a chronic mental disorder caused by mental or psychological trauma after sudden events of a catastrophic or threatening nature. Synaptic plasticity is the core mechanism of PTSD and the main point of treatment of this disease. METHODS: Male Sprague Dawley rats were randomly divided into blank control (Ctrl), SPS (single-prolonged stress) model, SPS&S model (SPS and foot electric shock), SPS+EA (SPS plus electroacupuncture), and SPS&S+EA groups. Tranquilize Mind and Regulate Kidney (TMRK) electroacupuncture method was performed in each rat in the SPS+EA and SPS&S+EA groups, the treatment lasted for 20 minutes per day, simultaneously for 3 consecutive weeks. Behavioral evaluations, molecular tests, electron microscopy, electrophysiological testing were conducted following the treatment. RESULTS: First, electro-acupuncture can significantly improve the PTSD-like symptoms. Second, electro-acupuncture can up-regulate the long-term potentiation (LTP) in hippocampus, repair the synaptic morphology and improve BDNF levels in amygdala and hippocampus. Third, electroacupuncture can significantly up-regulate SYN, GAP43, and PSD95 protein levels and mRNA expression in amygdala and hippocampus. CONCLUSIONS: The effect of TMRK electro-acupuncture method on the regression of fear memory of PTSD rats may be through its repair of synaptic plasticity in amygdala and hippocampus.

4 December 2018 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
YPYangzhi Peng
Yangzhi Peng
CZChengchen Zhang
Chengchen Zhang
YSYue Su
Yue Su
ZWZewen Wang
Zewen Wang
YJYong Jiang
Yong Jiang

22 January 2021 in Medicine
Verified
Journal Article
Open access
MZMao Zhao
Mao Zhao
YJYuchang Jiang
Yuchang Jiang
ZCZhaoxing Chen
Zhaoxing Chen
ZFZhipeng Fan
Zhipeng Fan
YJYong Jiang
Yong Jiang
Background: Helicobacter pylori (Hp) is the only bacterium in the stomach. It is characterized by its ability to adhere to gastric mucosa and cause a series of pathological changes in the gastric mucosa. Modern research shows that Hp is an important pathogenic factor for chronic gastritis, gastroduodenal ulcer, and gastric cancer. Triple, quadruple, and triple combinations of antibacterial drugs, proton pump inhibitors, and bismuth aluminate preparations have been developed in modern medical research. Sequential therapy is used to treat Hp, but antibiotic resistance and repeated infections still exist. A large number of clinical trials have proved that traditional Chinese medicine has a good therapeutic effect on Hp. In this systematic review, we aim to evaluate the efficacy and safety of traditional Chinese medicine in the treatment of Hp. Methods and analysis: We will search for publications from Web of Science, PubMed, Science Direct, Wan Fang Data Knowledge Service Platform, Chinese Biomedical Literature Database (CBM), Chinese Scientific Journal Database (VIP database), China National Knowledge Infrastructure (CNKI) and EMBASE, which should be published from inception to December 2020. Two researchers will independently perform the selection of the studies, data extraction, and synthesis. The Cochrane Risk of Bias Tool will be used to evaluate the risk of bias in the randomized controlled trials. Statistical analysis will be performed by using the Cochrane Review Manager (RevMan 5.3) software. The I 2 test will be used to identify the extent of heterogeneity. We will use the Egger funnel chart to evaluate possible publication biases, in addition, when possible we will perform a subgroup/meta-regression analysis. The strength of the evidence will be assessed according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results and conclusions: This study will systematically evaluate the efficacy of traditional Chinese medicine in the treatment of Hp infection, and provide evidence for the clinical application of this treatment. The results of the research will be published in a peer-reviewed journal. Ethics: This systematic review will evaluate the efficacy of traditional Chinese medicine for Hp infection. Because all data used in this systematic review and meta-analysis have been published, this review does not require ethical approval. Trial registration number: INPLASY2020120057.

24 December 2020 in Medicine
Verified
Journal Article
Open access
CWChanghong Wang
Changhong Wang
YJYong Jiang
Yong Jiang
ZFZhipeng Fan
Zhipeng Fan
MZMao Zhao
Mao Zhao
YJYuchang Jiang
Yuchang Jiang
ZCZhaoxing Chen
Zhaoxing Chen
Background: Asthma is one of the most common chronic diseases in the world, with ∼100 million asthma patients worldwide. China has become one of the countries with the highest asthma death rate in the world. Asthma is a chronic airway inflammatory disease. Patients with this disease may have symptoms such as cough, wheezing, and difficulty breathing. For many years, Western medicine has mainly used anti-inflammatory, anti-bronchial spasm, asthma, cough, and oxygen to treat this disease, but the effect is not good. Tuina is a common treatment for asthma in China. But at present, there is no systematic evaluation report on its therapeutic effectiveness and safety. This protocol aims to reveal the efficacy and safety of Tuina for treating asthma. Methods: The following databases will be searched by electronic methods: PubMed, EBASE, WHO International Clinical Trials Registry Platform, Embase, the Chinese Biomedical Literature Database (CBM), Wan-fang Data (WANFANG), the China National Knowledge Infrastructure (CNKI), and other sources from inception to November 2020. Bias risk, subgroup analysis, data synthesis, and meta-analyses will be assessed with RevMan V.5.3 software if the data is met inclusion conditions. Results: This study will present a quality evidence of Tuina for the treatment of astma patients. Conclusion: The systematic review will present reliable evidence to judge whether or not Tuina is a safe and effective intervention for asthma patients. International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) registration number: INPLASY2020110100.

28 February 2023 in Postgraduate Medical Journal
Verified
Journal Article
Closed access
PDF file
ZFZhipeng Fan
Zhipeng Fan
HSHong-Fei Song
Hong-Fei Song
RYRongli Yuan
Rongli Yuan
YPYangzhi Peng
Yangzhi Peng
YJYong Jiang
Yong Jiang
The associations between female infertility and epithelial ovarian cancer (EOC) or endometrial cancer (EC) have been reported in observational studies, but its causal relationship remains unknown. We intended to assess the causal effect of female infertility on EOCs and ECs using a two-sample Mendelian Randomization (MR) approach. Large pooled genome-wide association study (GWAS) datasets for female infertility (6481 cases and 68 969 controls), EOC (25 509 cases and 40 941 controls), and EC (12 906 cases and 108 979 controls) were derived from public GWAS databases and published studies. The Inverse Variance Weighted method, Weighted Median method, MR-Egger regression, and MR-Pleiotropy Residual Sum and Outlier test were adopted for MR analyses. Our results suggested that genetically predicted infertility was positively associated with the risk of EOC (OR = 1.117, 95% CI = 1.003–1.245, P = .045), but did not find a causal relationship between infertility and EC (OR = 1.081, 95% CI = 0.954–1.224, P = .223). As to the reverse direction, our study did not obtain evidence from genetics that EOCs (OR = 0.974, 95% CI = 0.825–1.150, P = .755) and ECs (OR = 1.039, 95% CI = 0.917–1.177, P = .548) were associated with an increased risk of infertility. This large MR analysis supported a causal association between female infertility and increased risk of EOCs, but did not find a causal relationship between infertility and ECs. What is already known on this topic: Many studies have revealed that some people are more susceptible to undergoing cancers than others. Understanding the risk drivers that confer cancer risk will provide vital information to help public health officials make decisions that will benefit these at-risk populations. Observational studies have shown that female infertility is a high risk factor for ovarian cancer and endometrial cancer (EC), but the causal relationship has not been established. What this study adds: Our two-sample Mendelian Randomization study supported a causal association between female infertility and increased risk of epithelial ovarian cancers (EOCs), but did not find a causal relationship between infertility and ECs. No clear evidence was found for a potential causal effect of EOCs and ECs on female infertility. How this study might affect research, practice, or policy Our findings suggested that patients with infertility were at higher risk of developing EOC compared to the general population. Increased knowledge and regular surveillance of EOC in infertile women may help to identify early EOC.

11 December 2020 in Medicine
Verified
Journal Article
Open access
JDJiashuai Deng
Jiashuai Deng
SLSixuan Li
Sixuan Li
YPYangzhi Peng
Yangzhi Peng
ZCZhaoxing Chen
Zhaoxing Chen
CWChanghong Wang
Changhong Wang
YJYong Jiang
Yong Jiang
Background: : Previous cesarean scar defect (PCSD) is a gynecological disease that can cause bleeding after intercourse, prolonging menstrual period, intermenstrual bleeding, dysmenorrhea, and even lead to infertility. Chinese herbal medicine plays an important role in the treatment of gynecological diseases in China and East Asia. This study aims to assess the efficacy and safety of Chinese herbal medicine for PCSD. Methods: : We search the following databases: PubMed, the Cochrane Library, Chinese Biomedical Literature Database (CB), Chinese Science and Technique Journals Database (VIP), EMBASE, Chinese National Knowledge Infrastructure Database (CNKI), and the Wanfang Database. Other sources will also be searched like Google Scholar and gray literature. All databases mentioned above are searched from the start date to the latest version. Randomized controlled trials will be included which recruiting PCSD participants to assess the efficacy and safety of Chinese herbal medicines against controls (placebo or other therapeutic agents). Primary outcomes will include the size of PCSD, menstrual cycle, menstrual phase, menstrual volume, duration of disease, security index. Two authors will independently scan the searched articles, extract the data from attached articles, and import them into Endnote X8 and use Microsoft Excel 2013 to manage data and information. We will assess the risk of bias by Cochrane tool of risk of bias. Disagreements will be resolved by consensus or the participation of a third party. All analysis will be performed based on the Cochrane Handbook for Systematic Reviews of Interventions. The meta-analysis in this review will use RevMan 5.3 software. Results: : The study aims to evaluate the efficacy and safety of the treatment that Chinese herbal medicine for PCSD. Conclusion: : This study of the meta-analysis could provide evidence for clinicians and help patients to make a better choice. INPLASY registration number: INPLASY202090080